Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths

Although nearly 10% of Americans suffer from a rare disease, clinical progress in individual rare diseases is severely compromised by lack of attention and research resources compared to common diseases. It is thus imperative to investigate these diseases at their most basic level to build a foundat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Peter A. Kropp (Autor), Rosemary Bauer (Autor), Isabella Zafra (Autor), Carina Graham (Autor), Andy Golden (Autor)
Format: Knjiga
Izdano: The Company of Biologists, 2021-08-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno